SQUAWK/NEWS
Account
Account
Menu
Live NewsCategoriesequity

AIM ImmunoTech Inc. (AIM) News

Track canonical SquawkNews coverage tagged to AIM, AIM ImmunoTech Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 7 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol AIM Asset equity Sector Markets 90 days 7 Last 0.2508 Updated Aug 12, 2026, 12:44 PM UTC Open live news feed
H AIM - AIM ImmunoTech CEO Highlights Biodefense and Military Force Protection in Newly Published ‘Breaking Defense’ Article - Click For Relea AIM - AIM ImmunoTech CEO Highlights Biodefense and Military Force Protection in Newly Published ‘Breaking Defense’ Article EQUITY | Aug 12, 2026, 12:44 PM UTC H AIM ImmunoTech Ahead on DURIPANC Trial AIM ImmunoTech reaches critical clinical inflection point EQUITY | Aug 03, 2026, 12:33 PM UTC L Great Western Mining Corporation PLC Announces Exercise of Warrants and Issue of Equity DUBLIN, IRELAND / / July 3, 2026 / Great Western Mining Corporation PLC (AIM:GWMO)(ESM:8GW) announces that it ha EQUITY | Jul 03, 2026, 11:30 AM UTC L Update on Intention to Move from AIM to Main Market Reykjavík, July 03, 2026 (GLOBE NEWSWIRE) -- THIS ANNOUNCEMENT IS MADE FOR INFORMATION EQUITY | Jul 03, 2026, 06:00 AM UTC H RTX CORP - RAYTHEON INCREASES AIM-9X MISSILE PRODUCTION CAPACITY TO 2500 PER YEAR RTX CORP - RAYTHEON INCREASES AIM-9X MISSILE PRODUCTION CAPACITY TO 2500 PER YEAR GEOPOLITICS | Jun 26, 2026, 12:01 PM UTC M AIM Outlines Milestones AIM ImmunoTech outlines upcoming milestones, including DURIPANC primary endpoint analysis expected in December 2026 EARNINGS | Jun 24, 2026, 12:36 PM UTC